Cidara Therapeutics, Inc. ($CDTX)
Filing Information
| Accession Number | 0001683607-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 7, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
35,390
Total Value
$3,322.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 7, 2026 | Sale to Issuer | 15 | $221.50 | $3,322.50 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 7, 2026 | Sale to Issuer | 1,750 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 7, 2026 | Sale to Issuer | 875 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 7, 2026 | Sale to Issuer | 1,400 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 7, 2026 | Sale to Issuer | 2,125 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 7, 2026 | Sale to Issuer | 2,125 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 7, 2026 | Sale to Issuer | 16,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 7, 2026 | Sale to Issuer | 11,100 | โ | โ | 0 | Direct | โ | View Details |